Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Further re:- Suspension

4 Mar 2020 09:15

RNS Number : 9823E
Asimilar Group PLC
04 March 2020
 

4 March 2020

 

 

Asimilar Group plc

("Asimilar" or the "Company")

 

Further re:- Suspension

 

 

Further to the announcement of 14 February 2020 in relation to the temporary suspension of the Company's shares from trading on AIM, the Company makes the following update.

 

The Company continues its discussions with Sentiance NV ("Sentiance"), a leading player in artificial intelligence ("AI"), machine learning and contextual behavioural data science, and intends to publish an admission document and to convene a General Meeting seeking shareholder approval for the readmission of the Company's shares to trading on AIM.

 

Subject to regulatory consents, the Company will seek shareholder approval to subscribe for 10,000 new Sentiance shares at a price of €750 per share for an aggregate consideration of €7,500,000 ("Initial Investment"). The Initial Investment would represent circa 9.3% of the enlarged share capital of Sentiance.

 

In addition, the Company would be granted an option to purchase 32,225 existing Sentiance shares at an exercise price of €650 per share ("Option 1") and a further option to subscribe for 10,000 new shares in Sentiance at an exercise price of €750 per share ("Option 2"). Shareholder consent would also be sought to enter into both Option 1 and Option 2.

 

Following the Initial Investment and assuming both Option 1 and Option 2 were exercised the Company would have an interest over circa 44.5% of Sentiance's so enlarged issued share capital, assuming no other Sentiance shares were issued, but is currently expected to have an aggregate interest of nearer 35.9% following the anticipated issue of further Sentiance shares to a third party and the exercise of share options by management and staff.

 

Due to the aggregate size of the proposed investment and the options relative to the Company's existing portfolio, the proposal will be classified as a reverse takeover under the AIM Rules and therefore will be conditional, inter alia, upon the approval of shareholders.

 

The Board confirms that the Company's shares will continue to be suspended pursuant to AIM Rule 40 pending the publication of an admission document with further details in relation to the proposed investments and fundraise, however, there is no guarantee that any definitive agreement will be reached with Sentiance.

Further announcements will be made in due course.

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURKKQBDCBKKNNK
Date   Source Headline
1st Apr 20213:58 pmRNSExercise of Warrants
31st Mar 20216:04 pmRNSExtension of Warrant Exercise Date
30th Mar 20217:00 amRNSAnnual Report and Accounts and Portfolio Update
29th Mar 20215:32 pmRNSExercise of Warrants & Vesting of Warrants
26th Mar 20213:36 pmRNSExercise of Warrants
22nd Mar 20211:17 pmRNSHolding(s) in Company
18th Mar 20217:00 amRNSCompletion of Subscription
9th Mar 20212:06 pmRNSUpdate re MESH
1st Mar 202111:02 amRNSDev Clever Subscription
25th Feb 20217:00 amRNSAssignment of Subscription Rights
17th Feb 20214:29 pmRNSExercise of Warrants
15th Feb 202111:35 amRNSAnnouncement of Agreement by MESH re Sentiance
27th Jan 20217:00 amRNSUpdate re: Dev Clever Subscription Rights
26th Jan 20217:00 amRNSUpdate re subscription in Dev Clever
18th Jan 20219:51 amRNSExercise of Warrants
13th Jan 20218:28 amRNSExercise of Warrants
12th Jan 20214:41 pmRNSSecond Price Monitoring Extn
12th Jan 20214:35 pmRNSPrice Monitoring Extension
31st Dec 20207:00 amRNSFurther Equity Investment in SeeQuestor
21st Dec 20207:30 amRNSStatement re Announcement by Dev Clever
17th Dec 20207:00 amRNSDirector's Disclosure
7th Dec 20207:00 amRNSFurther Investment in Magic Media Works
1st Dec 20207:00 amRNSFurther conditional investment in Dev Clever
30th Nov 20204:08 pmRNSAssignment of Sentiance Loan
24th Nov 20207:00 amRNSDirector's Dealing
9th Nov 20202:49 pmRNSUpdate re Magic Media Works Limited
9th Nov 20207:00 amRNSFurther Investment in SeeQuestor
2nd Nov 20207:00 amRNSUpdate re Dev Clever Subscription Rights
26th Oct 202011:21 amRNSResult of AGM
23rd Oct 20207:00 amRNSExercise of Warrants
20th Oct 20207:00 amRNSAward of Warrants to Director
7th Oct 20204:40 pmRNSSecond Price Monitoring Extn
7th Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSNotice of AGM & Update re Loan to Sentiance
29th Sep 20203:18 pmRNSHolding(s) in Company
23rd Sep 20203:24 pmRNSBoard Changes
16th Sep 202012:57 pmRNSExercise of Warrants
10th Sep 202012:00 pmRNSUpdate re: Dev Clever Holdings plc
8th Sep 20202:39 pmRNSMarket Update
7th Sep 20207:00 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSExercise of Subscription rights
1st Sep 20207:00 amRNSAcquisition of Intrinsic Capital (Jersey) Ltd
1st Sep 20207:00 amRNSUpdate to Right to Subscribe
25th Aug 20207:30 amRNSRestoration - Asimilar Group plc
25th Aug 20207:00 amRNSCompletion of Agreement & Lifting of Suspension
20th Aug 202011:29 amRNSMESH AGM
3rd Aug 20203:12 pmRNSAgreement with MESH Holdings plc
31st Jul 202012:14 pmRNSUpdate re. Suspension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.